Carry Life@ UF System Clinical Study
Not Applicable
- Conditions
- End Stage Renal Disease
- Interventions
- Drug: 2.27% glucose peritoneal dialysis dwellDevice: Carry Life UF
- First Posted Date
- 2023-05-25
- Last Posted Date
- 2025-02-26
- Lead Sponsor
- Triomed AB
- Target Recruit Count
- 25
- Registration Number
- NCT05874804
- Locations
- 🇮🇹
ASST-Cremona, Cremona, Italy
🇮🇹Polyclinic Milan, Milan, Italy
🇮🇹P.O. San Giovanni Bosco, Torino, Italy
A Performance Analysis of the Peritoneal Ultrafiltration (PUF) Achieved With the Carry Life® UF
Not Applicable
Completed
- Conditions
- Chronic Renal Failure
- Interventions
- Device: Carry Life UF device
- First Posted Date
- 2018-10-30
- Last Posted Date
- 2019-08-28
- Lead Sponsor
- Triomed AB
- Target Recruit Count
- 8
- Registration Number
- NCT03724682
- Locations
- 🇸🇪
Skånes Universitetssjukhus, Lund, Lund, Sweden
🇸🇪Skånes Universitetssjukhus, Malmö, Malmö, Skåne, Sweden
🇸🇪Karolinska Universitetssjukhuset, Stockholm, Sweden
A Feasibility Study of Peritoneal Dialysis With CLS PD, Which Removes Toxins and Maintains a Stable Ultrafiltration by Continuously Regenerating a Recirculating Intraperitoneal Fluid, in Patients With End Stage Renal Disease, ESRD, With PD Therapy.
Not Applicable
Completed
- Conditions
- Peritoneal Dialysis
- Interventions
- Device: lCarry Life System Peritoneal Dialysis (CLS PD)
- First Posted Date
- 2017-06-16
- Last Posted Date
- 2018-04-17
- Lead Sponsor
- Triomed AB
- Target Recruit Count
- 5
- Registration Number
- NCT03190018
- Locations
- 🇸🇪
Sahlgrenska University Hospital, Gothenburg, Västra Götalands Regionen, Sweden
A Feasibility Study of Peritoneal Ultrafiltration With a Wearable Device, CLS UF, That Adds a Glucose-salt Solution to the Intraperitoneal Fluid in the Device, in Order to Maintain a Stable Intraperitoneal Osmolarity and Thereby Enhance Ultrafiltration.
Not Applicable
Completed
- Conditions
- Ultrafiltration Failure
- Interventions
- Device: Carry life system, ultrafiltration (CLS UF)
- First Posted Date
- 2017-04-25
- Last Posted Date
- 2018-03-16
- Lead Sponsor
- Triomed AB
- Target Recruit Count
- 5
- Registration Number
- NCT03128073
- Locations
- 🇸🇪
Kidney Unit, Malmö, Skåne, Sweden
A Clinical Study of the Safety and Efficacy of a Wearable Device (CLS UF) That Delivers Continuous Administration of Glucose to Recirculated Peritoneal Dialysis Fluid for the Purpose of Ultrafiltration in Patients With Congestive Heart Failure
Not Applicable
Terminated
- Conditions
- Cardio-Renal SyndromeHeart Failure
- Interventions
- Device: CLS UF
- First Posted Date
- 2016-05-13
- Last Posted Date
- 2017-03-14
- Lead Sponsor
- Triomed AB
- Target Recruit Count
- 2
- Registration Number
- NCT02772146
- Locations
- 🇩🇪
Division of Nephrology, Heidelberg University Hospital, Heidelberg, Germany
© Copyright 2025. All Rights Reserved by MedPath